193 related articles for article (PubMed ID: 37905148)
41. The coagulopathy of acute promyelocytic leukaemia revisited.
Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
43. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
44. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
[TBL] [Abstract][Full Text] [Related]
46. Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia.
Nakasaki T; Wada H; Mori Y; Okugawa Y; Watanabe R; Nishikawa M; Gabazza EC; Masuya M; Kageyama S; Kumeda K; Kato H; Shiku H
Am J Hematol; 2000 Jul; 64(3):145-50. PubMed ID: 10861807
[TBL] [Abstract][Full Text] [Related]
47. Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia.
Ruhnke L; Stölzel F; Wagenführ L; Altmann H; Platzbecker U; Herold S; Rump A; Schröck E; Bornhäuser M; Schetelig J; von Bonin M
Front Oncol; 2021; 11():666014. PubMed ID: 33937079
[TBL] [Abstract][Full Text] [Related]
48. The α2-Plasmin Inhibitor-Plasmin Complex is a Potential Biomarker of Venous Thromboembolism in Orthopedic Trauma Patients.
Guo X; Tao H; Li D; Li Y
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865270
[TBL] [Abstract][Full Text] [Related]
49. Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer.
Kasthuri RS; Hisada Y; Ilich A; Key NS; Mackman N
Res Pract Thromb Haemost; 2020 May; 4(4):636-643. PubMed ID: 32548563
[TBL] [Abstract][Full Text] [Related]
50. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
Schwartz BS; Williams EC; Conlan MG; Mosher DF
Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
[TBL] [Abstract][Full Text] [Related]
51. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
52. Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts.
Smith P; Rosell A; Farm M; Bruzelius M; Aguilera Gatica K; Mackman N; Odeberg J; Thålin C
PLoS One; 2022; 17(7):e0270865. PubMed ID: 35901107
[TBL] [Abstract][Full Text] [Related]
53. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer.
Hisada Y; Garratt KB; Maqsood A; Grover SP; Kawano T; Cooley BC; Erlich J; Moik F; Flick MJ; Pabinger I; Mackman N; Ay C
Blood Adv; 2021 Jan; 5(2):487-495. PubMed ID: 33496742
[TBL] [Abstract][Full Text] [Related]
54. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
[TBL] [Abstract][Full Text] [Related]
55. Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis.
Klaassen ILM; Lauw MN; Fiocco M; van der Sluis IM; Pieters R; Middeldorp S; van de Wetering MD; de Groot-Kruseman HA; van Ommen CH
Res Pract Thromb Haemost; 2019 Apr; 3(2):234-241. PubMed ID: 31011707
[TBL] [Abstract][Full Text] [Related]
56. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.
Ma G; Liu F; Lv L; Gao Y; Su Y
Ann Hematol; 2013 May; 92(5):645-52. PubMed ID: 23344645
[TBL] [Abstract][Full Text] [Related]
57. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
[TBL] [Abstract][Full Text] [Related]
58. Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
Reiner MF; Müller D; Gobbato S; Stalder O; Limacher A; Bonetti NR; Pasterk L; Méan M; Rodondi N; Aujesky D; Angelillo-Scherrer A; Matter CM; Lüscher TF; Camici GG; von Eckardstein A; Beer JH
Thromb Res; 2019 Feb; 174():40-47. PubMed ID: 30553164
[TBL] [Abstract][Full Text] [Related]
59. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
Schnegg-Kaufmann A; Calzavarini S; Limacher A; Mean M; Righini M; Staub D; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Husmann M; Banyai M; Aschwanden M; Mazzolai L; Hugli O; Nagler M; Daskalakis M; Rodondi N; Aujesky D; Angelillo-Scherrer A
J Thromb Haemost; 2019 Feb; 17(2):306-318. PubMed ID: 30570809
[TBL] [Abstract][Full Text] [Related]
60. Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey.
Lee EJ; Smith BD; Merrey JW; Lee AI; Podoltsev NA; Barbarotta L; Litzow MR; Prebet T; Luger SM; Gore S; Streiff MB; Zeidan AM
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):766-770. PubMed ID: 26363982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
